Qube Research & Technologies Ltd - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q2 2022$1,073,000
+166.9%
54,015
+348.4%
0.01%
+33.3%
Q3 2020$402,00012,0470.01%
Other shareholders
ALBIREO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 174,791$6,556,0003.03%
Sio Capital Management, LLC 354,210$13,286,0002.72%
Birchview Capital, LP 92,000$3,451,0001.99%
Chicago Capital, LLC 618,263$23,191,0001.04%
Perceptive Advisors 2,360,139$88,529,0000.95%
Endurant Capital Management LP 42,292$1,586,0000.57%
Artal Group S.A. 700,000$26,257,0000.56%
Cormorant Asset Management, LP 500,000$18,755,0000.45%
Samsara BioCapital, LLC 100,000$3,751,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 257,372$9,654,0000.34%
View complete list of ALBIREO PHARMA INC shareholders